Last reviewed · How we verify

NCT06056037

Making ART Work Among Brazilian Youth

Recruiting now NA Last updated 19 September 2025
What this trial tests

NA trial testing Experimental: Making ART Work in Hiv in 72 participants. Currently enrolling.

Timeline
1 October 2023
Primary endpoint
30 April 2026
30 April 2026

Quick facts

Lead sponsorBrown University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment72
Start date1 October 2023
Primary completion30 April 2026
Estimated completion30 April 2026
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Brown University

Who can join

Adults 18 to 24, male only, with Hiv or Adherence, Medication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study seeks to develop and pilot test a theory-based, integrated technology and counseling intervention to improve ART adherence among sexual and gender minority (SGM) young people living with HIV (ages 18-24) in Rio de Janeiro, Brazil. The intervention aims to improve social support, self-efficacy for taking ART, and teach skills for problem-solving barriers to promote better adherence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hiv

Currently open trials in the same condition.

Other Brown University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06056037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing